| Incidence and survival rates of contemporary patients with invasive upper tract urothelial carcinoma CC Ruvolo, L Nocera, LF Stolzenbach, M Wenzel, V Cucchiara, Z Tian, ... European urology oncology 4 (5), 792-801, 2021 | 56 | 2021 |
| Comparison of machine learning algorithms to predict clinically significant prostate cancer of the peripheral zone with multiparametric MRI using clinical assessment categories … S Bernatz, J Ackermann, P Mandel, B Kaltenbach, Y Zhdanovich, ... European radiology 30, 6757-6769, 2020 | 46 | 2020 |
| Triplet or doublet therapy in metastatic hormone-sensitive prostate cancer patients: a systematic review and network meta-analysis P Mandel, B Hoeh, M Wenzel, F Preisser, Z Tian, D Tilki, T Steuber, ... European Urology Focus 9 (1), 96-105, 2023 | 43 | 2023 |
| Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a … M Wenzel, L Nocera, C Colla Ruvolo, C Würnschimmel, Z Tian, ... Prostate cancer and prostatic diseases 25 (2), 139-148, 2022 | 40 | 2022 |
| Clinical outcomes and adverse events after first-line treatment in metastatic renal cell carcinoma: a systematic review and network meta-analysis L Nocera, PI Karakiewicz, M Wenzel, Z Tian, SF Shariat, F Saad, ... The Journal of Urology 207 (1), 16-24, 2022 | 39 | 2022 |
| Performance of combined magnetic resonance imaging/ultrasound fusion-guided and systematic biopsy of the prostate in biopsy-naïve patients and patients with prior biopsies F Preisser, L Theissen, M Wenzel, C Humke, B Bodelle, J Köllermann, ... European Urology Focus 7 (1), 39-46, 2021 | 38 | 2021 |
| Overall survival after systemic treatment in high-volume versus low-volume metastatic hormone-sensitive prostate cancer: systematic review and network meta-analysis M Wenzel, C Würnschimmel, L Nocera, CC Ruvolo, Z Tian, SF Shariat, ... European urology focus 8 (2), 399-408, 2022 | 37 | 2022 |
| Life expectancy in metastatic prostate cancer patients according to racial/ethnic groups C Würnschimmel, M Wenzel, C Colla Ruvolo, L Nocera, Z Tian, F Saad, ... International Journal of Urology 28 (8), 862-869, 2021 | 28 | 2021 |
| Regional lymph node metastasis on prostate specific membrane antigen positron emission tomography correlates with decreased biochemical recurrence-free and therapy-free … T Amiel, C Würnschimmel, M Heck, T Horn, N Nguyen, L Budäus, ... The Journal of Urology 205 (6), 1663-1670, 2021 | 28* | 2021 |
| Survival after radical prostatectomy versus radiation therapy in high-risk and very high-risk prostate cancer F Chierigo, M Wenzel, C Würnschimmel, RS Flammia, B Horlemann, ... The Journal of Urology 207 (2), 375-384, 2022 | 27 | 2022 |
| Radical prostatectomy for localized prostate cancer: 20-year oncological outcomes from a German high-volume center C Würnschimmel, M Wenzel, N Wang, Z Tian, PI Karakiewicz, M Graefen, ... Urologic Oncology: Seminars and Original Investigations 39 (12), 830. e17 …, 2021 | 26 | 2021 |
| Management and treatment options for patients with de novo and recurrent hormone-sensitive oligometastatic prostate cancer F Preisser, S Banek, M Wenzel, M Graefen, T Steuber, D Tilki, P Mandel Prostate international 9 (3), 113-118, 2021 | 25 | 2021 |
| Dusting, fragmenting, popcorning or dustmenting? M Wenzel, M Bultitude, J Salem Current Opinion in Urology 29 (2), 108-112, 2019 | 25 | 2019 |
| Increasing rates of NCCN high and very high‐risk prostate cancer versus number of prostate biopsy cores M Wenzel, C Würnschimmel, CC Ruvolo, L Nocera, Z Tian, F Saad, ... The prostate 81 (12), 874-881, 2021 | 24 | 2021 |
| Impact of time to castration resistance on survival in metastatic hormone sensitive prostate cancer patients in the era of combination therapies M Wenzel, F Preisser, B Hoeh, M Schroeder, C Wuernschimmel, ... Frontiers in oncology 11, 659135, 2021 | 24 | 2021 |
| Tumor size predicts muscle-invasive and non–organ-confined disease in upper tract urothelial carcinoma at radical nephroureterectomy CC Ruvolo, L Nocera, LF Stolzenbach, M Wenzel, G Califano, Z Tian, ... European Urology Focus 8 (2), 498-505, 2022 | 20 | 2022 |
| Incidence rates and contemporary trends in primary urethral cancer M Wenzel, L Nocera, C Colla Ruvolo, C Würnschimmel, Z Tian, ... Cancer Causes & Control 32, 627-634, 2021 | 20 | 2021 |
| Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma L Nocera, LF Stolzenbach, CC Ruvolo, M Wenzel, Z Tian, G Rosiello, ... European Journal of Surgical Oncology 47 (5), 1187-1190, 2021 | 20 | 2021 |
| Tumor stage and substage predict cancer-specific mortality after nephrectomy for nonmetastatic renal cancer: histological subtype-specific validation L Nocera, CC Ruvolo, LF Stolzenbach, M Wenzel, Z Tian, A Larcher, ... European urology focus 8 (1), 182-190, 2022 | 19 | 2022 |
| Inverse stage migration in radical prostatectomy—A sustaining phenomenon B Hoeh, F Preisser, P Mandel, M Wenzel, C Humke, MN Welte, M Müller, ... Frontiers in Surgery 8, 612813, 2021 | 19 | 2021 |
Christoph WürnschimmelLuzerner Kantonsspital, Lucerne, Switzerland /// Martini-Klinik Prostate Cancer Center, Hamburg在 uke.de 的电子邮件经过验证
